<i>Caenorhabditis elegans</i> as an <i>in vivo</i> model to assess fucoidan bioactivity preventing <i>Helicobacter pylori</i> infection

Abstract

fucoidan, resulting in a significant improvement in lifespan, lowered H. pylori concentration in the digestive tract, and increased egg-laying pattern. New research lines proposing this compound as an active agent in nutraceutical and preventive novel therapies should be opened.